Stephanie Feng

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Stephanie Feng is an author at University of California, San Francisco specializing in molecular marker profiling, immune checkpoint inhibitors, and pathology.

Publications per year

2023–2023

Publications

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer

Tanya Jindal, Xiaolin Zhu, Rohit Bose et al. · Frontiers in Oncology · 2023 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin

Tanya Jindal, Li Zhang, Prianka Deshmukh et al. · Clinical Genitourinary Cancer · 2023 · 14 citations · Full text

Medicine, Oncology, Pathology +17

1–2 of 2